Holen Sie sich die Stockscreener-App
4.93
1.20%
-0.06
Handel nachbörslich:
4.79
-0.14
-2.84%
Schlusskurs vom Vortag:
$4.99
Offen:
$4.96
24-Stunden-Volumen:
4,543
Relative Volume:
0.44
Marktkapitalisierung:
$14.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-8.87%
1M Leistung:
+1.34%
6M Leistung:
-69.24%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.82
$5.1299
1-Wochen-Bereich:
$4.82
$5.96
52-Wochen-Spanne:
$4.44
$18.22
Traws Pharma Inc Stock (TRAW) Company Profile
Firmenname
Traws Pharma Inc
Sektor
Branche
Telefon
267-759-3680
Adresse
12 PENNS TRAIL, NEWTOWN
Vergleichen Sie TRAW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TRAW | 4.93 | 14.79M | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Traws Pharma Inc Aktie (TRAW) Neueste Nachrichten
Traws Pharma Reports Q3 Financials and Updates on Clinical Advances - MSN
Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger - TipRanks
Traws Pharma Reports Promising Antiviral Drug Progress - TipRanks
Traws Pharma earnings missed by $8.56, revenue topped estimates - Investing.com Canada
Traws Pharma Inc (TRAW) Quarterly 10-Q Report - Quartz
Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results - The Manila Times
Traws Pharma Reports Promising Phase 1 Data Despite Widening Q3 Losses | TRAW Stock News - StockTitan
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update - Marketscreener.com
Traws Pharma regains Nasdaq compliance with bid price - Investing.com India
Traws Pharma regains Nasdaq compliance with bid price By Investing.com - Investing.com UK
Expert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza Treatment - StockTitan
Traws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid ... - Yahoo Finance
Traws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir Marboxil - MyChesCo
Onconova Therapeutics stock hits 52-week low at $4.87 - Investing.com India
Traws Pharma reports positive Phase 1 flu drug results - Investing.com
Traws Pharma reports positive Phase 1 flu drug results By Investing.com - Investing.com Canada
Traws Pharma announces topline Phase 1 data for tivoxavir marboxil - TipRanks
Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - GlobeNewswire
Traws Pharma, Inc. Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil - Marketscreener.com
Onconova Therapeutics stock hits 52-week low at $4.87 By Investing.com - Investing.com Australia
Traws Pharma announces results from its early stage trial for its COVID candidate - MSN
Promising Phase 1 Results for Traws Pharma’s COVID Treatment Candidate - MSN
Traws Pharma reports promising Phase 1 trial for COVID drug - Investing.com
Traws Pharma announces topline Phase 1 results for ratutrelvir - TipRanks
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor - GlobeNewswire
Traws Pharma faces Nasdaq delisting over bid price issue By Investing.com - Investing.com Canada
Traws Pharma faces Nasdaq delisting over bid price issue - Investing.com India
Onconova Therapeutics stock hits 52-week low at $6 - Investing.com India
Onconova Therapeutics stock hits 52-week low at $6 By Investing.com - Investing.com South Africa
Financial Metrics Check: Traws Pharma Inc. (TRAW)’s Ratios for Trailing Twelve Months - The Dwinnex
Traws Pharma Welcomes Luba Greenwood Amid Strategic Board Changes - MyChesCo
Traws Pharma, Inc. Announces Board Changes - Marketscreener.com
Traws Pharma appoints new director, bids farewell to Marino - Investing.com
Was anything positive for Traws Pharma Inc. (TRAW) stock last session? - US Post News
Traws Pharma Appoints Luba Greenwood to Board of Directors - citybiz
Traws Pharma appoints Luba Greenwood to board of directors - TipRanks
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors - GlobeNewswire
Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting - MSN
Closing Figures Unveiled: Traws Pharma Inc. (TRAW) Drop -10.26, Closes at 0.31 - The Dwinnex
Traws Pharma Inc. (TRAW) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Onconova Therapeutics stock hits 52-week low at $0.32 - Investing.com
Traws Pharma Announces Stock Split, Share Adjustments, and Growth Strategy - TipRanks
Traws Pharma announces results of 2024 Special Meeting of Stockholders - TipRanks
Finanzdaten der Traws Pharma Inc-Aktie (TRAW)
Es liegen keine Finanzdaten für Traws Pharma Inc (TRAW) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):